BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kesner AJ, Lovinger DM. Cannabis use, abuse, and withdrawal: Cannabinergic mechanisms, clinical, and preclinical findings. J Neurochem 2021;157:1674-96. [PMID: 33891706 DOI: 10.1111/jnc.15369] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Sayson LV, Ortiz DM, Lee HJ, Kim M, Custodio RJP, Yun J, Lee CH, Lee YS, Cha HJ, Cheong JH, Kim HJ. Deletion of Cryab increases the vulnerability of mice to the addiction-like effects of the cannabinoid JWH-018 via upregulation of striatal NF-κB expression. Front Pharmacol 2023;14. [DOI: 10.3389/fphar.2023.1135929] [Reference Citation Analysis]
2 Lamanna-Rama N, MacDowell KS, López G, Leza JC, Desco M, Ambrosio E, Soto-Montenegro ML. Neuroimaging revealed long-lasting glucose metabolism changes to morphine withdrawal in rats pretreated with the cannabinoid agonist CP-55,940 during periadolescence. Eur Neuropsychopharmacol 2023;69:60-76. [PMID: 36780817 DOI: 10.1016/j.euroneuro.2023.01.005] [Reference Citation Analysis]
3 Ding H, Kiguchi N, Mabry KM, Kishioka S, Ko MC. Functional consequences of short-term exposure to opioids versus cannabinoids in nonhuman primates. Neuropharmacology 2023;223:109328. [PMID: 36356937 DOI: 10.1016/j.neuropharm.2022.109328] [Reference Citation Analysis]
4 Gómez-cañas M, Rodríguez-cueto C, Satta V, Hernández-fisac I, Navarro E, Fernández-ruiz J. Endocannabinoid-Binding Receptors as Drug Targets. Methods in Molecular Biology 2023. [DOI: 10.1007/978-1-0716-2728-0_6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Lichenstein SD. THC, CBD, and Anxiety: a Review of Recent Findings on the Anxiolytic and Anxiogenic Effects of Cannabis’ Primary Cannabinoids. Curr Addict Rep 2022. [DOI: 10.1007/s40429-022-00450-7] [Reference Citation Analysis]
6 Kurt Tunagur EM, Yazici AB, Guzel D, Tunagur MT, Ermis C, Suda MA, Yazici E. Investigating associations between appetite-regulating hormones, aggression and craving in males with cannabis use disorder. Drug Alcohol Depend 2022;238:109577. [PMID: 35905593 DOI: 10.1016/j.drugalcdep.2022.109577] [Reference Citation Analysis]
7 Kesner AJ, Mateo Y, Abrahao KP, Ramos-Maciel S, Pava MJ, Gracias AL, Paulsen RT, Carlson HB, Lovinger DM. Changes in striatal dopamine release, sleep, and behavior during spontaneous Δ-9-tetrahydrocannabinol abstinence in male and female mice. Neuropsychopharmacology 2022;47:1537-49. [PMID: 35478010 DOI: 10.1038/s41386-022-01326-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Fuchs Weizman N, Wyse BA, Montbriand J, Jahangiri S, Librach CL. Cannabis significantly alters DNA methylation of the human ovarian follicle in a concentration-dependent manner. Mol Hum Reprod 2022:gaac022. [PMID: 35674367 DOI: 10.1093/molehr/gaac022] [Reference Citation Analysis]
9 Lin A, O'Connor M, Behnam R, Hatef C, Milanaik R. Edible marijuana products and potential risks for pediatric populations. Curr Opin Pediatr 2022;34:279-87. [PMID: 35634702 DOI: 10.1097/MOP.0000000000001132] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Setién-Suero E, Ayesa-Arriola R, Peña J, Crespo-Facorro B, Ojeda N. Longitudinal effects of cannabis use on attentional processes in patients with first episode of psychosis. Schizophr Res 2022;244:71-80. [PMID: 35640355 DOI: 10.1016/j.schres.2022.05.011] [Reference Citation Analysis]
11 Missig G, Mehta N, Robbins JO, Good CH, Iliopoulos-Tsoutsouvas C, Makriyannis A, Nikas SP, Bergman J, Carlezon WA Jr, Paronis CA. Altered sleep during spontaneous cannabinoid withdrawal in male mice. Behav Pharmacol 2022;33:195-205. [PMID: 35288510 DOI: 10.1097/FBP.0000000000000674] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
12 Landucci E, Mazzantini C, Lana D, Giovannini MG, Pellegrini-giampietro DE. Neuronal and Astrocytic Morphological Alterations Driven by Prolonged Exposure with Δ9-Tetrahydrocannabinol but Not Cannabidiol. Toxics 2022;10:48. [DOI: 10.3390/toxics10020048] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
13 Vuilleumier C, Scherbaum N, Bonnet U, Roser P. Cannabinoids in the Treatment of Cannabis Use Disorder: Systematic Review of Randomized Controlled Trials. Front Psychiatry 2022;13:867878. [PMID: 35815028 DOI: 10.3389/fpsyt.2022.867878] [Reference Citation Analysis]
14 Ramaekers JG, Theunissen EL, van Ruitenbeek P, Mason NL. Cannabis Use and Neuroadaptation: A Call for Δ (9) -Tetrahydrocannabinol Challenge Studies. Front Psychiatry 2022;13:870750. [PMID: 35492732 DOI: 10.3389/fpsyt.2022.870750] [Reference Citation Analysis]
15 Kesner AJ, Mateo Y, Abrahao KP, Ramos-maciel S, Pava MJ, Gracias AL, Paulsen RT, Carlson HB, Lovinger DM. Sex-dependent changes in murine striatal dopamine release, sleep, and behavior during spontaneous Δ-9-tetrahydrocannabinol abstinence.. [DOI: 10.1101/2021.12.01.470765] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Helander A, Johansson M, Andersson A, Villén T. Analytical and medico-legal problems linked to the presence of delta-8-tetrahydrocannabinol (delta-8-THC): Results from urine drug testing in Sweden. Drug Test Anal 2021. [PMID: 34734479 DOI: 10.1002/dta.3190] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
17 Lawrence AJ. Should we or shouldn't we?: Preface to the Special Issue "Neurochemistry of Reward-Seeking". J Neurochem 2021;157:1405-7. [PMID: 33891317 DOI: 10.1111/jnc.15317] [Reference Citation Analysis]